Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 96 (11) , 2843-2853
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Increased Risk of Herpes Zoster in Children with Asthma: A Population-Based Case-Control StudyThe Journal of Pediatrics, 2013
- Herpes ZosterNew England Journal of Medicine, 2013
- Inappropriate prescribing of inhaled corticosteroids: are they being prescribed for respiratory tract infections? A retrospective cohort studyPrimary Care Respiratory Journal, 2013
- Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus ErythematosusClinical Therapeutics, 2013
- Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort studyBMC Pulmonary Medicine, 2011
- Inappropriate Overuse of Inhaled Corticosteroids for COPD Patients: Impact on Health Costs and Health StatusLung, 2011
- Investigation of relative risk estimates from studies of the same population with contrasting response rates and designsBMC Medical Research Methodology, 2010
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α AgentsJAMA, 2009
- Cohort Profile: The 45 and Up StudyInternational Journal of Epidemiology, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005